THE TREATMENT OF EUTHYROID CARDIAC PATIENTS WITH INTRACTABLE ANGINA PECTORIS AND CONGESTIVE FAILURE WITH RADIOACTIVE IODINE*†
- 1 October 1950
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 10 (10) , 1270-1281
- https://doi.org/10.1210/jcem-10-10-1270
Abstract
The therapeutic results of hypothyroidism induced by radioactive iodine (I131) in 23 euthyroid patients with intractable angina pectoris or congestive failure are reported. The duration of observation after induction of hypothyroidism varied from 3-22 mos. and averaged 15.5 mos. In 6 additional patients treated with therapeutic doses, the period of observation has been too short for evaluation, and hypothyroidism has not yet developed. Persistent hypothyroidism can be regularly induced by 1 or more appropriate doses of I131. No radiation sickness and no toxic effects on the blood or kidneys were observed. There was no thyroiditis in 10 patients; mild or moderate transitory thyroiditis in 18, and severe thyroiditis in 1. Temporary mild hyperthyroidism occurred in 2 patients. Each patient received orally a total of from 25.5-176 millicuries of I131 in single or divided doses. The largest single dose was 56 millicuries. The avg. total dose was 61 millicuries. In 8 patients studied, the radiation delivered to the thyroid gland was 28,800-56,100 R.E.P. In 3 patients, hypothyroidism was induced in from 9-14 weeks with 28,800-43,700 R.E.P. Angina pectoris was strikingly lessened or abolished in 11 of the 17 patients with intractable cardiac pain. Several patients were rehabilitated and are gainfully employed. Concomitant congestive failure, present in several of these patients, was likewise improved. In the other 6 of the 17 patients, angina pectoris was relieved when the patients were myxedematous, but recurred when desiccated thyroid was administered in order to ameliorate the discomfort of myxedema. 4 of 6 patients, incapacitated primarily because of congestive heart failure, showed worthwhile improvement; in 3 of these the improvement was striking. In the clinical management of these patients, we have attempted to maintain the lowest metabolic rate consistent with the comfort of the patient and have administered small doses of desiccated thyroid after the induction of myxedema.Keywords
This publication has 9 references indexed in Scilit:
- Hypothyroidism Produced by Radioactive Iodine (I 131 ) in the Treatment of Euthyroid Patients with Angina Pectoris and Congestive Heart FailureCirculation, 1950
- A NEW SIMPLE METHOD FOR ACCURATE MEASUREMENT OF URINARY I131AFTER TRACER AND THERAPEUTIC DOSES*Journal of Clinical Endocrinology & Metabolism, 1950
- COMPARATIVE VALUE AND ACCURACY OF MEASUREMENTS OF URINARY I131BY BETA AND BY GAMMA RAY COUNTING*Journal of Clinical Endocrinology & Metabolism, 1949
- Clinical Experience in Diagnosis and Treatment of Thyroid Disorders with Radioactive Iodine (Eight-Day Half-Life)Radiology, 1948
- THE TREATMENT OF ANGINA PECTORIS WITH PROPYLTHIOURACILAnnals of Internal Medicine, 1948
- Treatment of Euthyroid Cardiac Patients by Producing Myxedema with Radioactive Iodine.Experimental Biology and Medicine, 1948
- A study of cardiac pain by means of local anaesthesia of the precordium and section of the sympathetic pathwaysActa Medica Scandinavica, 1948
- TOXIC MANIFESTATIONS OF THIOURACIL THERAPYJAMA, 1946
- Thiouracil as a Cause of Neutropenia and AgranulocytosisNew England Journal of Medicine, 1945